IP Library Granted Patent US 8,629,253
Granted Patent B2
US 8,629,253 · App. 11/590,434 · Granted Jan 14, 2014

Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis

Inventors: Paul Schimmel (La Jolla, CA); Keisuke Wakasugi (Shizuoka, JP)
Assignee: The Scripps Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,629,253
App. No.
11/590,434
Granted
Jan 14, 2014
Kind
B2
Abstract

Nucleic acids encoding tRNA synthetase polypeptides useful for regulating angiogenesis are disclosed. Methods of making and using such nucleic acids are also disclosed.

Claims (32)

1. An isolated nucleic acid encoding a mature polypeptide and comprising a coding region consisting of a nucleotide sequence selected from the group consisting of:

(a) a polynucleotide encoding a polypeptide consisting of amino acid residues 1-364 of SEQ ID NO: 2;

(b) a polynucleotide consisting of nucleotide residues 3428-4519 of SEQ ID NO: 1, which encodes amino acid residues 1-364 of SEQ ID NO: 2; and

(c) a polynucleotide that is hybridizable to a polynucleotide consisting of nucleotide residues 3428-4519 of SEQ ID NO: 1, which encodes amino acid residues 1-364 of SEQ ID NO: 2.

2. The isolated nucleic acid of claim 1 wherein the nucleotide sequence further comprises a loader polynucleotide in open reading frame with the coding region, the leader polynucleotide encoding a secretory peptide sequence for controlling transport of the mature polypeptide from a cell.

3. The isolated nucleic acid of claim 1 wherein the nucleotide sequence comprises sequential nucleotide deletions from either the 5′-terminus or the 3′-terminus.

4. The isolated nucleic acid of claim 3 wherein the nucleotide sequence further comprises a leader polynucleotide in open reading frame with the coding region, the leader polynucleotide encoding a secretory peptide sequence for controlling transport of the mature polypeptide from a cell.

5. A isolated recombinant host cell that expresses an isolated polypeptide encoded by the nucleic acid of claim 1 .

6. An isolated nucleic acid encoding a mature polypeptide and comprising a coding region consisting of a nucleotide sequence selected from the group consisting of:

(a) a polynucleotide encoding a polypeptide comprising amino acid residues 1-364 of SEQ ID NO: 2; and

(b) a polynucleotide comprising nucleotide residues 3428-4519 of SEQ ID NO: 1, which encodes amino acid residues 1-364 of SEQ ID NO: 2;

(c) a polynucleotide that is hybridizable to a polynucleotide comprising nucleotide residues 3428-4519 of SEQ ID NO: 1, which encodes amino acid residues 1-364 of SEQ ID NO: 2;

wherein the isolated nucleic acid does not encode residues 365-528 of SEQ ID NO: 2.

7. The isolated nucleic acid of claim 6 wherein the nucleotide sequence further comprises a leader polynucleotide in open reading frame with the coding region, the leader polynucleotide encoding a secretory peptide sequence for controlling transport of the mature polypeptide from a cell.

8. The isolated nucleic acid of claim 6 wherein the nucleotide sequence comprises sequential nucleotide deletions from either the 5′-terminus or the 3′-terminus.

9. The isolated nucleic acid of claim 8 wherein the nucleotide sequence further comprises a leader polynucleotide in open reading frame with the coding region, the leader polynucleotide encoding a secretory peptide sequence for controlling transport of the mature polypeptide from a cell.

10. A recombinant vector comprising the nucleic acid molecule of claim 6 .

11. A recombinant vector comprising the nucleic acid molecule of claim 7 .

12. A recombinant vector comprising the nucleic acid molecule of claim 8 .

13. A recombinant vector comprising the nucleic acid molecule of claim 9 .

14. A method of making a recombinant host cell comprising introducing the nucleic acid of claim 6 into the host cell.

15. A method of making a recombinant host cell comprising introducing the nucleic acid of claim 7 into the host cell.

16. A method of making a recombinant host cell comprising introducing the nucleic acid of claim 8 into the host cell.

17. A method of making a recombinant host cell comprising introducing the nucleic acid of claim 9 into the host cell.

18. A isolated recombinant host cell comprising the nucleic acid of claim 6 .

19. A isolated recombinant host cell comprising the nucleic acid of claim 7 .

20. A isolated recombinant host cell comprising the nucleic acid of claim 8 .

21. A isolated recombinant host cell comprising the nucleic acid of claim 9 .

22. A isolated recombinant host cell that expresses an isolated polypeptide encoded by the nucleic acid of claim 6 .

23. A method of making an isolated polypeptide comprising:

(a) culturing the recombinant host cell of claim 22 in which said polypeptide is expressed; and

(b) isolating expressed polypeptide from the cell culture.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 11, 2014
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032670/0556 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Oct 14, 2008
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021681/0056 →
Continuity (3)
Division 10240527
Provisional Application 60193471 · Mar 31, 2000
Related Publication 20070048322A1 · Mar 1, 2007